Table 1.
Participant List for Convening on the Influenza Human Challenge Model for Universal Influenza Vaccine Development.
| Participants | |
| Pedro A. Piedra, MD | Baylor College of Medicine |
| Asha Abraham, MD, PhD | Christian Medical College, Vellore, Tamil Nadu, India |
| Stacey Wooden, PhD, MPH | Human Vaccines Project |
| Adolfo Garcia-Sastre, PhD; Florian Krammer, PhD | Icahn School of Medicine at Mount Sinai |
| Behazine Combadiere, PhD | Inserm |
| Claudia Emerson, PhD | McMaster University, Institute on Ethics & Policy for Innovation |
| Punnee Pitisuttithum, MD, DTMH | Mahidol University, Vaccine Trial Centre, Faculty of Tropical Medicine |
| Matthew Memoli, MD, MS | NIAID LID Clinical Studies Unit |
| John Oxford, PhD | Queen Mary College |
| Mark McKinlay, PhD | Task Force for Global Health, Center for Vaccine Equity |
| Ab Osterhaus, PhD, DVM | TiHo Hannover Research Center for Emerging Infection & Zoonoses |
| Eduard Schmidt, PhD | UNISEC Consortium |
| Rebecca Jane Cox, PhD | University of Bergen Influenza Centre |
| Donald Milton, MD, DrPH | University of Maryland School of Public Health |
| Kathleen Neuzil, MD, MPH, FIDSA | University of Maryland Center for Vaccine Development and Global Health |
| Arnold S. Monto, MD | University of Michigan, School of Public Health |
| Frederick Hayden, MD | University of Virginia School of Medicine |
| Yoshihiro Kawaoka, PhD | University of Wisconsin-Madison/University of Tokyo |
| Shabir Madhi, PhD | University of the Witwatersrand |
| Policy | |
| Dora Navarro Torne, MD, PhD, PharmD | DG RTD European Commission |
| Philipp Lambach, MD, MBA, PhD | World Health Organization |
| Surveillance and Reference Laboratories | |
| Luzhao Feng, MD, PhD | Chinese Center for Disease Control & Prevention |
| John McCauley, PhD | Francis Crick Institute, WHO Collaborating Centre for Reference and Research on Influenza |
| Maria Zambon, PhD | Public Health England |
| Joseph Bresee, MD; David Wentworth, PhD | US Centers for Disease Control & Prevention |
| Zhiping Ye, MD, PhD | US Food & Drug Administration Laboratory of Respiratory Viruses Diseases |
| Regulatory | |
| Marco Cavaleri, PhD | European Medicine Agency Anti-Infectives and Vaccines Division |
| Othmar Engelhardt, Dr nat techn | National Institute for Biological Standards and Control |
| Jerry Weir, PhD | US Food & Drug Administration Division of Viral Products |
| Hana Golding, PhD | US Food & Drug Administration Laboratory of Retrovirus Research, Center for Biologics Evaluation and Research |
| Industry/Product Development | |
| Lidia Oostvogels, MD; Susanne Rauch, PhD | CureVac AG |
| Marie Van Der Wielen, MD | GSK Vaccines |
| Andrew Catchpole, DPhil | hVivo |
| Vivek Shinde, MD, MPH | Novavax, Inc. |
| Bruce Innis, MD; Francesco Berlanda Scorza, PhD; Gene Saxon, MEng, MME | PATH |
| Saranya Sridhar, MD, PhD, MPH | Sanofi Pasteur |
| Jonathan Edelman, MD; Beverly Taylor, PhD | Seqirus, Inc. |
| Adrian Wildfire, MSc | SGS Life Sciences |
| John Treanor | Tunnell Government Services |
| Sean Tucker, PhD | Vaxart, Inc. |
| Funders | |
| Anastazia Older Aguilar, PhD; Jeremy Blum, PhD; Keith Chirgwin, MD; Varsha Jain, MD; Keith Klugman, MD, PhD; Niteen Wairagkar, MD; Janet White, MBA | Bill & Melinda Gates Foundation |
| Armen Donabedian, PhD | Biomedical Advanced Research and Development Authority, Flu & EID Vaccines |
| Marc Ouellette, PhD | Canadian Institutes of Health Research Institute of Infection and Immunity |
| Casey Wright, MSc | Flu Lab |
| Emily Erbelding, MD, MPH; Diane Post, PhD; Chris Roberts, PhD | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health |
| Shobana Balasingam, MSc; Cecilia Chui, DPhil; Zoe Seager, PhD | Wellcome Trust |